PlainPharmaWatch

CMS Open Payments · Tool

Stereotaxis Inc vs Impel Pharmaceuticals LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Stereotaxis Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 679, versus 36 for the other company. Its single largest recorded recipient represents 0.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Stereotaxis Inc
HHI 679 · top recipient 0.1%
Ranked #1,182 of 1,838 companies by HHI
Impel Pharmaceuticals LLC
HHI 36 · top recipient 0.0%
Ranked #1,785 of 1,838 companies by HHI

Payment Overview

Company A

Stereotaxis Inc

Total Payments
$15.7K
% of Industry
0.0%
Transactions
180
Avg per Transaction
$87.28
Recipients
180
Avg per Recipient
$87.28
Payment Types
2
Top Payment Type
Travel and Lodging
Total Payments
$15.8K
% of Industry
0.0%
Transactions
1,000
Avg per Transaction
$15.81
Recipients
1,000
Avg per Recipient
$15.81
Payment Types
1
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

Stereotaxis Inc vs Impel Pharmaceuticals LLC - total reported payments in CMS Open Payments PY2024

Impel Pharmaceuticals LLC$15.8KStereotaxis Inc$15.7K

Payment Types Breakdown

Stereotaxis Inc

Travel and Lodging $10.0K

63.7%

Entertainment $5.7K

36.3%

Impel Pharmaceuticals LLC

Food and Beverage $15.8K

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Stereotaxis Inc

  1. 1

    Nathaniel David McConkey

    $2,352.84 · 6 txns

  2. 2

    Matthew Hakimi

    $1,906.24 · 13 txns

  3. 3

    William Gionfriddo

    $1,427.98 · 14 txns

  4. 4

    Raghuveer Dendi

    $1,141.63 · 6 txns

  5. 5

    Bradley M Bacik

    $990.56 · 4 txns

Impel Pharmaceuticals LLC

  1. 1

    ROGER CHAPMAN

    $190.05 · 12 txns

  2. 2

    JESSICA HORWITZ

    $171.23 · 10 txns

  3. 3

    NICOLE ROTHMAN

    $165.65 · 8 txns

  4. 4

    ERIC BARON

    $150.96 · 12 txns

  5. 5

    AURORA PAJEAU

    $149.04 · 7 txns

Summary Comparison

Metric Stereotaxis Inc Impel Pharmaceuticals LLC
Total Payments $15.7K $15.8K
% of Industry Total 0.0% 0.0%
Transaction Count 180 1,000
Avg per Transaction $87.28 $15.81
Recipient Count 180 1,000
Avg per Recipient $87.28 $15.81
Payment Type Count 2 1
Top Payment Type Travel and Lodging Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.